Source map — Bristol Myers claims Phase 2 success for GPRC5D-directed CAR-T
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| Endpoints News | news | 60% |
| Fierce Biotech | news | 60% |
| Reuters | news | 60% |
| FirstWord Pharma | news | 60% |
| OncLive | news | 60% |
| finance.yahoo.com | news | 50% |